Create Alert
Watchlist

Alembic Pharmaceuticals

₹903.75
+2.75 (0.31%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
903.70
Prev. Close
901.00
Volume
2,20,526
Total traded value
19.93 Cr
Upper Circuit
1,084.50
Lower Circuit
723.00

Fundamentals

Market Cap₹17,731Cr
ROE11.93%
P/E Ratio(TTM)28.07
EPS(TTM)32.14
P/B Ratio3.33
Dividend Yield1.22%
Industry P/E33.01
Book Value270.62
Debt to Equity0.28
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Alembic Pharmaceuticals

Established in 1907, Alembic Pharmaceuticals is a prominent research-driven, integrated pharmaceutical company that specializes in producing generic medicines and active pharmaceutical ingredients (APIs) for global markets. The company's core mission is to improve healthcare worldwide by focusing on innovation, maintaining a strong commitment to quality, and building trust with patients and healthcare providers. It leverages its expertise in chemistry and formulation to create high-quality, affordable medicines, making healthcare more accessible to a wider population across the globe. Its operations are strategically structured into three key areas: selling branded medicines in India, exporting generic drugs internationally, and manufacturing Active Pharmaceutical Ingredients. Headquartered in Vadodara, Gujarat, the company operates several advanced, FDA-approved manufacturing facilities in Gujarat and Sikkim which form the backbone of its global supply capabilities. With 756 cumulative product filings across the world, Alembic has established a strong and expanding presence in both regulated and emerging international pharma markets.;
Parent OrganisationAlembic Pharmaceuticals
Managing DirectorChirayu Amin
NSE SymbolAPLLTD

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
69.74%
Retail And Others
9.92%
Mutual Funds
8.55%
Other Domestic Institutions
7.75%
Foreign Institutions
4.05%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
40.73
Cipla
NA
(0.00%)
22.47
Dr Reddy's Laboratories
NA
(0.00%)
18.11
Zydus Lifesciences
NA
(0.00%)
18.50